- Home
- BUI vs LAB Comparison
BUI vs LAB Comparison
Compare BUI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUI
- LAB
- Stock Information
- Founded
- BUI 2011
- LAB 1999
- Country
- BUI United States
- LAB United States
- Employees
- BUI N/A
- LAB N/A
- Industry
- BUI Trusts Except Educational Religious and Charitable
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- BUI Finance
- LAB Industrials
- Exchange
- BUI Nasdaq
- LAB Nasdaq
- Market Cap
- BUI 518.5M
- LAB 562.1M
- IPO Year
- BUI N/A
- LAB 2011
- Fundamental
- Price
- BUI $23.09
- LAB $1.30
- Analyst Decision
- BUI
- LAB Strong Buy
- Analyst Count
- BUI 0
- LAB 2
- Target Price
- BUI N/A
- LAB $2.88
- AVG Volume (30 Days)
- BUI 59.8K
- LAB 1.8M
- Earning Date
- BUI 01-01-0001
- LAB 02-26-2025
- Dividend Yield
- BUI 6.79%
- LAB N/A
- EPS Growth
- BUI N/A
- LAB N/A
- EPS
- BUI 2.75
- LAB N/A
- Revenue
- BUI N/A
- LAB $155,902,000.00
- Revenue This Year
- BUI N/A
- LAB $62.60
- Revenue Next Year
- BUI N/A
- LAB $9.19
- P/E Ratio
- BUI $7.77
- LAB N/A
- Revenue Growth
- BUI N/A
- LAB 48.23
- 52 Week Low
- BUI $18.73
- LAB $1.17
- 52 Week High
- BUI $24.22
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- BUI 46.89
- LAB 35.51
- Support Level
- BUI $23.00
- LAB $1.17
- Resistance Level
- BUI $23.50
- LAB $1.51
- Average True Range (ATR)
- BUI 0.32
- LAB 0.10
- MACD
- BUI 0.02
- LAB 0.00
- Stochastic Oscillator
- BUI 38.06
- LAB 32.50
About BUI BlackRock Utility Infrastructure & Power Opportunities Trust
BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing a strategy of writing (selling) call and put options.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.